A Case of Localized Tracheobronchial Relapsing Polychondritis with Positive Matrilin-1 Staining

Overview

Journal BMC Rheumatol

Specialty Rheumatology

Date 2020 Feb 5

PMID 32016169

Authors

Tomonori Makiguchi

Akira Koarai

Chihiro Inoue

Yayoi Aoyama

Taizo Hirano

Takashi Ohe

Tomohiro Ichikawa

Yutaka Shishikura

Hanae Komuro

Yoko Tsukita

Naoki Tode

Tadahisa Numakura

Tsutomu Saito

Teruyuki Sato

Yoshiya Mitsuhashi

Tsutomu Tamada

Hisatoshi Sugiura

Masakazu Ichinose

Affiliations

Soon will be listed here.

Abstract

Background: Relapsing polychondritis (RPC) is a rare progressive autoimmune disease characterized by inflammation in the cartilage of multiple organs. Tracheobronchial involvement appears in nearly half of RPC patients during the course of their disease and represents the main cause of death. Localized tracheobronchial RPC is much rarer, and the pathogenesis remains unclear. Matrilin-1 is a non-collagenous cartilage matrix protein and has been suggested to be a potent autoantigen that induces the airway disease of RPC in animal models. However, the expression of matrilin-1 in tracheobronchial tissue in human remains unclear. Therefore, we examined the expression of matrilin-1 in the tracheal and auricular tissues in a localized tracheobronchial RPC patient.

Case Presentation: A 62-year-old man with systemic sclerosis presented with cough and dyspnea on exertion. The lung function test showed an expiratory flow limitation and chest computed tomography showed diffuse thickness from the trachea to the bronchiole. No other tests showed abnormal findings. To evaluate further, bronchoscopy was performed and endobronchial ultrasonography showed thickness in the fourth-marginal echo layer suggesting inflammation of the cartilage. However, the tracheal biopsy showed no specific findings. The subsequent surgical tracheal biopsies showed inflammatory cell infiltration with destruction of the cartilage. Neither auricular nor nasal deformity, except for a tracheobronchial lesion, was detected. Biopsy from the left auricular cartilage also did not show any inflammatory changes. Finally, we diagnosed the patient with localized tracheobronchial RPC. To address the hypothesis that autoimmunity against matrilin-1 is involved in the pathogenesis of localized tracheobronchial RPC, we evaluated the expression level of matrilin-1 in a tracheal and auricular specimen from this patient. Immunohistochemical staining with anti-matrilin-1 antibody showed matrilin-1 in the tracheal but not in the auricular cartilage.

Conclusions: We first demonstrated the expression of matrilin-1 in tracheal but not in auricular cartilage in a localized tracheobronchial RPC patient. This result supports the possibility that matrilin-1 is involved in the pathogenesis of localized tracheobronchial RPC. However, this is only one case report and further observations will be needed to confirm this result.

References

Saxne T, Heinegard D . Serum concentrations of two cartilage matrix proteins reflecting different aspects of cartilage turnover in relapsing polychondritis. Arthritis Rheum. 1995; 38(2):294-6. DOI: 10.1002/art.1780380224. View

Maimon N, Marras T, Hwang D, Paul N, Keshavjee S, Chan C . A 46-year-old female with dyspnoea, stridor and chronic cough. Eur Respir J. 2006; 28(3):666-9. DOI: 10.1183/09031936.06.00146005. View

Suzuki S, Ikegami A, Hirota Y, Ikusaka M . Fever and cough without pulmonary abnormalities on CT: relapsing polychondritis restricted to the airways. Lancet. 2015; 385(9962):88. DOI: 10.1016/S0140-6736(14)61946-2. View

Ingegnoli A, Corsi A, Verardo E, De Filippo M, Sverzellati N, Zompatori M . Uncommon causes of tracheobronchial stenosis and wall thickening: MDCT imaging. Radiol Med. 2007; 112(8):1132-41. DOI: 10.1007/s11547-007-0211-z. View

Hansson A, Heinegard D, Holmdahl R . A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). J Clin Invest. 1999; 104(5):589-98. PMC: 408533. DOI: 10.1172/JCI5740. View

De Geeter F, Vandecasteele S . Fluorodeoxyglucose PET in relapsing polychondritis. N Engl J Med. 2008; 358(5):536-7. DOI: 10.1056/NEJMc072254. View

Wooley P, Luthra H, ODuffy J, Bunch T, Moore S, Stuart J . Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens. 1984; 23(5):263-9. DOI: 10.1111/j.1399-0039.1984.tb00043.x. View

Cantarini L, Vitale A, Brizi M, Caso F, Frediani B, Punzi L . Diagnosis and classification of relapsing polychondritis. J Autoimmun. 2014; 48-49:53-9. DOI: 10.1016/j.jaut.2014.01.026. View

Borgia F, Giuffrida R, Guarneri F, Cannavo S . Relapsing Polychondritis: An Updated Review. Biomedicines. 2018; 6(3). PMC: 6164217. DOI: 10.3390/biomedicines6030084. View

10.

Klatt A, Becker A, Neacsu C, Paulsson M, Wagener R . The matrilins: modulators of extracellular matrix assembly. Int J Biochem Cell Biol. 2010; 43(3):320-30. DOI: 10.1016/j.biocel.2010.12.010. View

11.

Tsunezuka Y, Sato H, Shimizu H . Tracheobronchial involvement in relapsing polychondritis. Respiration. 2000; 67(3):320-2. DOI: 10.1159/000029518. View

12.

Arnaud L, Mathian A, Haroche J, Gorochov G, Amoura Z . Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev. 2013; 13(2):90-5. DOI: 10.1016/j.autrev.2013.07.005. View

13.

McAdam L, OHanlan M, Bluestone R, Pearson C . Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976; 55(3):193-215. View

14.

Frances C, el Rassi R, Laporte J, Rybojad M, Papo T, Piette J . Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center. Medicine (Baltimore). 2001; 80(3):173-9. DOI: 10.1097/00005792-200105000-00003. View

15.

Hansson A, Heinegard D, Piette J, Burkhardt H, Holmdahl R . The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum. 2001; 44(10):2402-12. DOI: 10.1002/1529-0131(200110)44:10<2402::aid-art405>3.0.co;2-l. View

16.

Hansson A, Johannesson M, Svensson L, Nandakumar K, Heinegard D, Holmdahl R . Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease. Am J Pathol. 2004; 164(3):959-66. PMC: 1614711. DOI: 10.1016/S0002-9440(10)63183-5. View

17.

Miyazu Y, Miyazawa T, Kurimoto N, Iwamoto Y, Ishida A, Kanoh K . Endobronchial ultrasonography in the diagnosis and treatment of relapsing polychondritis with tracheobronchial malacia. Chest. 2003; 124(6):2393-5. DOI: 10.1378/chest.124.6.2393. View

18.

Jung C, Muller-Hocker J, Rauh G . Relapsing poly(peri)chondritis diagnosed by biopsy during inflammatory free interval: destructive polychondritis versus fibrosing perichondritis. Eur J Med Res. 1996; 1(12):554-8. View

19.

Saxne T, Heinegard D . Involvement of nonarticular cartilage, as demonstrated by release of a cartilage-specific protein, in rheumatoid arthritis. Arthritis Rheum. 1989; 32(9):1080-6. DOI: 10.1002/anr.1780320905. View

20.

Michet Jr C, McKenna C, Luthra H, OFallon W . Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986; 104(1):74-8. DOI: 10.7326/0003-4819-104-1-74. View